Effects of LMWH Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease

Trial Profile

Effects of LMWH Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Mar 2017

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Enoxaparin sodium
  • Indications Stroke; Thromboembolism; Venous thromboembolism
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 Apr 2016 Study design changed from randomised,cross over to Non-randomised and single group also dosage of study drugs modified
    • 15 Dec 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 24 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top